PRPO · Precipio, Inc.
$30.45
+1.02 (+3.47%)
At close · Aug 21
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Notwithstanding the aforementioned circumstances, there remains substantial doubt about the Company's ability to continue as a going concern over the next twelve months from the date of issuance of this Quarterly Report on Form 10-Q.”View the 10-Q filed Aug 14, 2026
Market Cap
$54.51M
Shares
1.79M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$24.05M
+29.8%
FY2025
Net Income
-$363K
+91.5%
FY2025
Gross Margin
44.52%
+3.7pp
FY2025
Operating Margin
-5%
+17.8pp
FY2025
Diluted EPS
-$0.23
+92.2%
FY2025
Operating Cash Flow
$685K
+56%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $27.2M | $24.05M | $18.53M | $15.2M | $9.41M | $8.85M | $6.09M | $3.13M | $2.86M | $1.72M | $1.72M | $1.93M | $1.24M | $27.54M | $31.48M | $31.97M | $20.05M | $22.02M | |
| $15.2M | $13.34M | $10.97M | $9.18M | $6.9M | $6.46M | $4.94M | $2.91M | $2.64M | $1.43M | $970K | $1.94M | $2.18M | $16.79M | $18.35M | $13.53M | $10.28M | $10.42M | |
| $12M | $10.71M | $7.56M | $6.02M | $2.51M | $2.39M | $1.15M | $219K | $225K | $292K | $753K | -$11K | -$935K | $10.75M | $13.13M | $18.44M | $9.76M | $11.61M | |
| — | 44.52% | 40.79% | 39.6% | 26.67% | 27.03% | 18.88% | 7% | 7.86% | 16.95% | 43.7% | -0.57% | -75.4% | 39.04% | 41.72% | 57.67% | 48.7% | 52.69% | |
| — | $1.6M | $1.3M | $1.7M | $1.7M | $1.3M | $1.2M | $1.2M | $1.1M | $500K | $0 | $1.85M | $2.25M | $3.21M | $2.49M | $2.22M | $2.31M | $3.18M | |
| — | — | — | — | — | — | $10.3M | $9.62M | $9.45M | $6.49M | $2.47M | $7.06M | $7.39M | $23.3M | $20.15M | $19.15M | $10.93M | $10.32M | |
| — | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1.2M | $600K | $200K | $100K | $100K | $1.8M | $1.4M | $1.3M | $100K | — | |
| — | $1.25M | $1.2M | $1.23M | $1.22M | $1.13M | $1.09M | $1.12M | $1.27M | $743K | $112K | $489K | $569K | $2.75M | $2.28M | $2.1M | $708K | $852K | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | $0 | $0 | $41K | $138K | $0 | |
| $13.54M | $11.91M | $11.78M | $13.64M | $15.31M | $12.01M | $10.3M | $11.21M | $14.14M | $15.8M | $2.47M | $8.91M | $9.63M | $26.51M | $22.64M | $21.41M | $13.38M | $13.5M | |
| -$1.55M | -$1.2M | -$4.22M | -$7.62M | -$12.8M | -$9.61M | -$9.15M | -$10.99M | -$13.91M | -$15.51M | -$1.71M | -$8.92M | -$10.57M | -$15.76M | -$9.5M | -$2.97M | -$3.61M | -$1.9M | |
| — | -5% | -22.75% | -50.14% | -135.96% | -108.63% | -150.13% | -351.58% | -485.75% | -900.23% | -99.36% | -462.36% | -852.34% | -57.21% | -30.19% | -9.3% | -18.02% | -8.61% | |
| — | $43K | -$3.02M | -$6.4M | -$11.58M | -$8.48M | -$8.05M | -$9.88M | -$12.65M | -$14.77M | -$1.6M | -$8.43M | -$10M | -$13.01M | -$7.23M | -$871K | -$2.9M | -$1.04M | |
| — | $839K | -$74K | — | — | — | — | — | — | — | $3000 | $0 | $0 | $60K | $11K | $259K | $632K | $3000 | |
| -$1.22M | -$363K | -$4.29M | -$5.85M | -$12.18M | -$8.52M | -$10.6M | -$13.31M | -$15.97M | -$20.69M | -$2.23M | -$9.86M | -$10.78M | -$16.04M | -$8.18M | -$9.74M | -$2.98M | -$1.88M | |
| — | $0 | $0 | $0 | $0 | $0 | $0 | -$70K | -$279K | $349K | $0 | $0 | $0 | -$54K | $146K | $45K | $150K | $42K | |
| -$1.22M | -$363K | -$4.29M | -$5.85M | -$12.18M | -$8.52M | -$10.6M | -$13.24M | -$15.69M | -$20.69M | -$2.23M | -$32.95M | -$13.94M | -$15.99M | -$8.33M | -$9.78M | -$3.13M | -$1.92M | |
| — | -1.51% | -23.15% | -38.51% | -129.39% | -96.25% | -173.97% | -423.5% | -547.97% | -1201.04% | -129.25% | -1708.35% | -1124.35% | -58.04% | -26.45% | -30.6% | -15.63% | -8.72% | |
| — | — | — | — | $25K | $13K | $27K | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | -$5.85M | -$12.2M | -$8.53M | -$13.97M | -$13.24M | -$19.92M | -$33.21M | -$4.08M | -$34.28M | -$15.09M | -$16.71M | -$8.99M | -$10.79M | -$3.13M | -$1.92M | |
| — | — | — | — | — | — | — | — | — | — | -$7.62M | -$33.28M | -$13.99M | -$16.03M | -$8.23M | -$9.73M | -$3.19M | — | |
| USD/shares | — | -$0.23 | -$2.93 | -$4.51 | -$10.73 | -$8.00 | -$17.00 | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$0.23 | -$2.93 | -$4.51 | -$10.73 | -$8.00 | -$17.00 | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 1.61M | 1.47M | 1.3M | 1.14M | 1.05M | 823.85K | 284.76K | 72.06K | 231.96K | 21.63K | 616.09K | 374.69K | 363.33K | 289.74K | 205.67K | 2.46M | — |
| shares | — | 1.61M | 1.47M | 1.3M | 1.14M | 1.05M | 823.85K | 284.76K | 72.06K | 231.96K | 21.63K | 616.09K | 374.69K | 363.33K | 289.74K | 205.67K | 2.46M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
1.90×
Peer median 1.10×
EV/EBIT
—
P/E (TTM)
—
Peer medians compare against the 11 similar-size Diagnostics & Research companies (of 49 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Single Reportable Segment | $24,049,000 | $18,532,000 | $15,197,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Service Revenue Net | $21,309,000 | $15,921,000 | $12,178,000 | $8,010,000 | $7,935,000 | $5,872,000 |
| Product | $2,740,000 | $2,611,000 | $3,019,000 | — | — | — |
| Other | — | — | $3,019,000 | $1,402,000 | $914,000 | $220,000 |
Key facts
CIK
1043961
CUSIP
74019L602
13F (30d)
17 filings
17 filers
Visit website
Investor relations